Abstract: An example medical stent for treating a body lumen is disclosed. The example stent includes an expandable scaffold having a first end region, a second end region and an outer surface. The stent further includes a first fixation member coupled to the expandable scaffold and a biodegradable material disposed along the first fixation member at a first tissue engagement region. Further, the biodegradable material is designed to degrade from a first configuration in which the biodegradable material shields the first fixation member from a target tissue site to a second configuration in which the first fixation member is engaged with the target tissue site.

Abstract: A medical device that includes: a first handle coupled to a first sheath; a second handle coupled to a second sheath, wherein at least a portion of the first sheath is disposed within a lumen of the second sheath; and a patch. In a first configuration, the first handle and the second handle may be separated by a first distance, and the patch may be disposed between a distal portion of the first sheath and a distal portion of the second sheath. In a second configuration, the first handle and the second handle may contact one another or may be separated by a second distance, wherein the second distance is smaller than the first distance, and wherein a distalmost end of the second sheath is proximal of a proximal end of the patch.

Abstract: This disclosure relates generally to medical devices, systems, and methods for activation of a photoactive agent during a medical procedure. In an aspect, a catheter system for activation of a photoactive agent may comprise a catheter comprising an elongate shaft comprising a proximal portion, a distal portion, and a first lumen extending along the elongate shaft. A first flexible circuit may be disposed about the distal portion of the elongate shaft. A plurality of first light-emitting diodes (LEDs) may be disposed along the first flexible circuit. A second flexible circuit may be disposed about the distal portion of the elongate shaft. A plurality of second LEDs may be disposed along the second flexible circuit. A control unit may be coupled to the proximal end of the elongate shaft. The communications cable may be disposed within the catheter and may electrically couple the first LEDs with the control unit.

Abstract: An implantable device having an adjustable passage therethrough. The passage may be adjustable to occlude or otherwise to regulate access or flow of materials therethrough. An elongated element may be inserted into the passage when in a closed configuration to selectively open the passage. For instance, the implantable device may be a tubular device with a twisted region closing the passage therethrough, and the elongated device may be configured to engage such twisted region and to be rotated to untwist the closed region. An additional tubular device with a passage therethrough may be inserted into the passage of the implantable device to hold open the passage for a selected period of time.

Abstract: A medical device that includes a body and a polymer matrix over the body. The polymer matrix includes a plurality of fibers defining a plurality of pores to permit tissue growth therethrough. The medical device includes a bio-adhesive coating at least partially covering the polymer matrix.

Abstract: A resurfacing device for removing a thin layer of diseased tissue while minimizing damage to the underlying tissue layers may include an expandable scaffold attached to a catheter shaft, at least one electrode disposed on the expandable scaffold, and a plurality of debridement elements disposed on an outer surface of the expandable scaffold. The expandable scaffold is positioned in apposition to the target tissue, the scaffold is expanded and the electrodes are activated to ablate diseased tissue. The scaffold is rotated to remove the ablated tissue.

Abstract: An example medical stent for treating a body lumen is disclosed. The example stent includes an expandable scaffold having a first end region, a second end region and an outer surface. The stent further includes a first fixation member coupled to the expandable scaffold and a biodegradable material disposed along the first fixation member at a first tissue engagement region. Further, the biodegradable material is designed to degrade from a first configuration in which the biodegradable material shields the first fixation member from a target tissue site to a second configuration in which the first fixation member is engaged with the target tissue site.

Abstract: A microfluidic intravital window includes an intravital imaging window adapted for implantation adjacent target tissue of a live animal, and a microfluidic fluid source and delivery system physically integrated into the window for controlled delivery of fluids to target tissue via the window. The microfluidic fluid source and delivery system is self-contained and completely located within the intravital imaging window, and includes at least one preloaded fluid reservoir, at least one fluid port in fluidic communication with both the at least one preloaded fluid reservoir and the target tissue, and at least one light activated fluid flow control device situated between the at least one preloaded fluid reservoir and at least one fluid port, to facilitate simultaneous in vivo viewing and remotely controlled fluid delivery to the target tissue.

Abstract: A microfluidic intravital window includes an intravital imaging window adapted for implantation adjacent target tissue of a live animal, and a microfluidic fluid source and delivery system physically integrated into the window for controlled delivery of fluids to target tissue via the window. The microfluidic fluid source and delivery system is self-contained and completely located within the intravital imaging window, and includes at least one preloaded fluid reservoir, at least one fluid port in fluidic communication with both the at least one preloaded fluid reservoir and the target tissue, and at least one light activated fluid flow control device situated between the at least one preloaded fluid reservoir and at least one fluid port, to facilitate simultaneous in vivo viewing and remotely controlled fluid delivery to the target tissue.